ETF Building Blocks Content Hub Get Ready for a Biotech ETF Comeback By Elle Caruso FitzgeraldFebruary 17, 2022
Innovative ETFs Content Hub Greater Regulatory Scrutiny Could Weigh on Biotech ETFs By Max ChenMarch 24, 2021
Innovative ETFs Content Hub Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
Equity ETF Content Hub Biotech ETFs Poised for Gains after Moderna Vaccine News By Ian YoungNovember 16, 2020
Beyond Basic Beta Content Hub Can’t Get Enough Biotech Exposure in Your Portfolio? By Ben HernandezOctober 29, 2020
Webcasts America’s ‘Financial First Responders’ Examine the 2020 Election By Max ChenOctober 21, 2020
Leveraged & Inverse Content Hub Short Sellers Back Off From Biotech ETFs By Ben HernandezSeptember 28, 2020
